Current Progress on the Regulation of Endogenous Molecules for Enhanced Chemodynamic Therapy

Jun Wang,Yina Liu,Tingting Cui,Huanghao Yang,Lisen Lin

DOI: https://doi.org/10.1039/d4sc02129k

IF: 8.4

2024-06-08

Chemical Science

Abstract:Chemodynamic therapy (CDT) is a potential cancer treatment strategy, which relies on Fenton chemistry to transform hydrogen peroxide (H 2 O 2 ) into highly cytotoxic reactive oxygen species (ROS) for tumor growth suppression. Although overproduced H 2 O 2 in cancerous tissues makes CDT a feasible and specific tumor therapeutic modality, the treatment outcomes of traditional chemodynamic agents still fall short of expectations. Reprogramming cellular metabolism is one of the hallmarks of tumors, which not only supports unrestricted proliferative demands in cancer cells, but also mediates the resistance of tumor cells against many antitumor modalities. Recent discoveries have revealed that various cellular metabolites including H 2 O 2 , iron, lactate, glutathione, and lipids have distinct effects on CDT efficiency. In this perspective, we intend to provide a comprehensive summary of how different endogenous molecules impact Fenton chemistry for deep understanding of mechanisms underlying endogenous regulation-enhanced CDT. Moreover, we point out the current challenges and offer our outlook on the future research directions of this field. We anticipate that exploring CDT through manipulating metabolism will yield significant advancements in tumor treatment.

chemistry, multidisciplinary

What problem does this paper attempt to address?

The problem that this paper attempts to solve is how to improve the effect of Chemodynamic Therapy (CDT) in cancer treatment. Specifically, the paper focuses on how to enhance the efficacy of CDT by regulating the endogenous metabolic pathways within tumor cells. CDT is a treatment method that utilizes the Fenton reaction to convert intracellular hydrogen peroxide (H₂O₂) into highly toxic hydroxyl radicals (•OH), thereby inhibiting tumor growth. However, traditional CDT relies on a single Fenton catalyst, and its treatment effect is not ideal. The main reason is that tumor cells can build a strong defense system through metabolic adaptation to evade the damage caused by ROS (reactive oxygen species), which greatly weakens the anti - cancer effect of CDT.

To overcome this challenge, researchers have begun to explore ways to improve the efficiency of CDT by regulating metabolic pathways within tumor cells, such as hydrogen peroxide (H₂O₂), iron, lactic acid, glutathione (GSH) and lipid metabolism. These metabolic pathways not only affect the substrate supply for the Fenton reaction, but also affect the reaction conditions (such as acidity), and thus affect the treatment effect of CDT. Therefore, the paper summarizes how different endogenous molecules affect Fenton - chemistry - mediated CDT, and discusses the latest progress in the design of CDT nanomedicines with metabolic regulation capabilities, as well as the challenges faced and future research directions. Researchers hope to significantly improve the application effect of CDT in tumor treatment by manipulating metabolic pathways.